Clinical Trials Logo

Malignant Neoplasm of Pancreas clinical trials

View clinical trials related to Malignant Neoplasm of Pancreas.

Filter by:
  • None
  • Page 1

NCT ID: NCT05669482 Recruiting - Metastatic Cancer Clinical Trials

Study of Avutometinib (VS-6766) +Defactinib With Gemcitabine and Nab-paclitaxel in Patients With Pancreatic Cancer

RAMP205
Start date: March 22, 2023
Phase: Phase 1/Phase 2
Study type: Interventional

This study will assess the safety and efficacy of avutometinib (VS-6766) and defactinib in combination with gemcitabine and nab-paclitaxel in patients with Pancreatic Ductal Adenocarcinoma (PDAC) who have been previously untreated.

NCT ID: NCT03616431 Completed - Pancreatic Neoplasm Clinical Trials

Pancreatic Cancer Dietary Assessment Study

PanDA
Start date: July 3, 2018
Phase:
Study type: Observational

This is a prospective observational study which aims to evaluate; The prevalence of pancreatic insufficiency in patients with pancreatic malignancies (adenocarcinoma and neuroendocrine tumours). The most appropriate diagnostic strategy. The impact that an adequate diagnosis and treatment may have on patients' outcome.

NCT ID: NCT01598194 Completed - Clinical trials for Malignant Neoplasm of Pancreas

Comparison of a Novel 22-gauge Core Biopsy Needle

Start date: January 30, 2012
Phase: N/A
Study type: Interventional

The goal of this clinical research study is to compare the performance of a newly available needle with reverse bevel design (called the EchoTip® Procoreā„¢ needle) with standard needles to see which needle gives better diagnostic information for pancreatic lesions.